Vervolg CASUS. september 2009 -inmiddels 6 kuren R-CVP ondergaan -restadiering: PR EN NU?
ASH 2014 update in lymphoma
New Agents in Management of Indolent B-Cell NHLs F B Hagemeister MD Department of Lymphoma/Myeloma M D Anderson Cancer Center Las Vegas, Nevada February.
New Agents in Management of Indolent B-Cell NHLs
vervolg CASUS
1 Press OW et al. Proc ASH 2011 ; Abstract 98. 2 Illidge T et al. Proc ASH 2011;Abstract 102.
Recurrent Follicular Lymphoma With a Short First Remission: How Aggressive Should We Be? Carla Casulo, MD Wilmot Cancer Institute University of Rochester.
Is there Long-Term Benefit from Maintenance Rituximab?
